Myriad RBM Growth, Revenue, Number of Employees and Funding

Overview

Location:
Austin, TX USA
Total Funding:N/A
Industry:Biotech
Founded:2002
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • Myriad RBM's estimated revenue is currently $16.7M per year.
  • Myriad RBM's estimated revenue per employee is $144310

Employee Data

  • Myriad RBM has 116 Employees.
  • Myriad RBM grew their employee count by 7% last year.
  • Myriad RBM currently has N/A job openings.

Executive Contacts

NameTitle
Dennis DentonVP, IS & Technology
Samuel LaBrieSVP Corporate Development
James MapesSVP/Chief Scientific Officer
Ralph McDadePresident
Janet YangDirector, Business Development--Western Region
Don BeamishVP Commercial Development
Kelley NitkaSr Director of Lab Operations
Raymond CaseyDirector of Manufacturing Myriad RBM
Margaret SandefurVP Quality Assurance/ Regulatory Compliance
karri ballardSenior Director, Clinical Research

What Is Myriad RBM?

Myriad RBM, Inc. is the world's leading multiplexed immunoassay testing laboratory, providing comprehensive protein biomarker services based on its Multi-Analyte Profiling (MAP) platform. This platform provides pre-clinical and clinical researchers with reproducible and quantitative data for a few or hundreds of proteins in a cost-effective manner. All services are performed in our CLIA certified laboratory. As a guide to drug development researchers, Myriad RBM also offers strategic biomarker services that include companion diagnostics, custom assay development, co-sponsored research programs, and innovative cell culture products. Myriad RBM's biomarker testing laboratory is a wholly owned subsidiary of Myriad Genetics, Inc. (MYGN).

keywords:N/A

116

Number of Employees

$16.7M

Revenue (est)

N/A

Current Jobs

7%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Bellicum Pharma...
$1.1M148-11%$301.8M
G-CON Manufactu...
$8.8M6133%
BioNews Service...
$8.7M6011%
Luminex Corpora...
$158.4M109410%
Family Tree DNA
$5.7M4018%
XBiotech USA
$10.9M7512%
Celling Bioscie...
$9M62-2%
Gradalis
$6.2M4343%$40M
Myriad RBM
$16.7M1167%
Selleck Chemica...
$22M1528%

Myriad RBM News

14-Sep-19 - Global Neurological Biomarkers Market 2019 – Quanterix ...

Quanterix, Myriad RBM, QIAGEN, ADx NeuroSciences, Merck, Euroimmun, Thermo Fisher, BioCrypton, ACOBIOM, Banyan Biomarkers, Olink ...

13-Sep-19 - Genetic Testing Market Benefits, Forthcoming Developments ...

... Inc.), Myriad Genetics, Inc. (Myriad RBM, Inc.), Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd., Eurofins Scientific, Illumina, Inc., ...

12-Sep-19 - Global Neurological Biomarkers Market 2019 Major ...

Key players operating world wide: Thermo Fisher, Merck, Bio-Rad Laboratories, Roche, QIAGEN, Athena Diagnostics, Myriad RBM, Cisbio ...